Arovella Therapeutics Ltd has released a press release.
SUDA Expands Patent Coverage For Sildenafil
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Story so far
Earlier from Arovella Therapeutics
- SUDA announces update on ZolpiMist in USA and Canada
- SUDA expands dialogue with World Health Organisation
- HC Berlin Pharma Update
- SUDA Completes Divestment of Subsidiary
- Divestment Of Non-Core Subsidiary
Later from Arovella Therapeutics
- Shareholder Update
- Settlement with HC Berlin Pharma and Rights Issue
- Prospectus for a Renounceable Pro Rata Offer
- Anagrelide Update
- Business Development Update
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics